LBG
TEVA icon

Lloyds Banking Group’s Teva Pharmaceuticals TEVA Stock Holding History

Lloyds Banking Group’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-75,982
Closed -$4.01M – 572
2014
Q1 		$4.01M Sell
75,982
-197
-0.3% -$9.11K 0.04% 336
2013
Q4 		$3.05M Buy
76,179
+33,575
+79% +$1.32M 0.03% 392
2013
Q3 		$1.61M Buy
42,604
+18,133
+74% +$707K 0.02% 453
2013
Q2 		$959K Buy
+24,471
New +$953K 0.01% 505

Other funds holding TEVA

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
MIP
Mondrian Investment Partners London, United Kingdom $6.69B AUM
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return

Lloyds Banking Group's TEVA Position: Q2 2014 in Review

Lloyds Banking Group sold out of Teva Pharmaceuticals (TEVA) in Q2 2014, closing a stake of 75,982 shares — an estimated $4.01M sold.

Lloyds Banking Group first reported a position in TEVA in Q2 2013 and held it in 4 quarters. The position peaked at $4.01M in Q1 2014. 779 funds tracked by Wall St. Rank hold TEVA as of Q2 2014.

  • Lloyds Banking Group reported no remaining Teva Pharmaceuticals position as of Q2 2014 after selling out during the quarter.
  • Lloyds Banking Group sold 75,982 Teva Pharmaceuticals shares in Q2 2014, an estimated $4.01M.
  • Lloyds Banking Group first reported a position in Teva Pharmaceuticals in Q2 2013 and held it in 4 quarters.
  • Lloyds Banking Group's Teva Pharmaceuticals position peaked at $4.01M in Q1 2014.
  • 779 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2014.

Based on Lloyds Banking Group's 13F filing for Q2 2014, filed 14 Aug 2014.